Arca Biopharma | ABIO - Sales Revenues


Arca Biopharma reported 0 in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 11.38K 10.23K Dec/2022
Amgen USD 9.9B 340M Dec/2025
Arca Biopharma 0 0 Mar/2025
Biogen USD 2.28B 250M Dec/2025
Brainstorm Cell Therapeutics 0 0 Mar/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Capricor Therapeutics USD 0 11.13M Mar/2025
Cipla INR 75.18B 710M Dec/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 1.89M 631K Sep/2025
CSL USD 8.33B 4.79B Dec/2025
Cytokinetics USD 17.76M 15.83M Dec/2025
Daiichi Sankyo JPY 558.11B 57.35B Dec/2025
Gilead Sciences USD 7.93B 130M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Grifols EUR 2.34B 159.69M Mar/2026
Laboratory Of America USD 3.52B 40M Dec/2025
Myriad Genetics USD 209.8M 4.1M Dec/2025
Otsuka Holdings JPY 650.15B 12.17B Dec/2025
Pfizer USD 17.58B 880M Dec/2025
United Therapeutics USD 790.2M 9.3M Dec/2025